DoseLens

DoseLens helps clinicians and patients reduce trial-and-error medication dosing by combining routine lab results, current meds, and optional pharmacogenomics (PGx) data into a single dosing and risk view. The app ingests FHIR data from EHRs (or patient-uploaded PDFs/CSV), flags high-risk drug–drug interactions, and highlights gene–drug guidance when available (e.g., CYP2C19, CYP2D6). It does not “auto-prescribe”; it generates a transparent recommendation packet: suggested starting dose ranges, monitoring intervals, and the exact guideline citations used. Patients get plain-language explanations and reminders for follow-up labs. Clinicians get a concise note they can paste into the chart plus an audit trail for compliance. Realistically, the hard part is integration and trust: the product must be conservative, explainable, and focused on a few high-impact meds first (anticoagulants, antidepressants, pain meds) to avoid becoming a noisy, ignored alert system.